Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
Abstract Anastrozole is an aromatase inhibitor. Anastrozole competitively inhibits the aromatase enzyme, which synthesizes estrogen. It is used for estrogen receptor-positive breast cancers. A woman with breast cancer and anastrozole-induced dermatitis is described; the cutaneous side effects associ...
Saved in:
Main Authors: | Yoo Jung Kim (Author), Philip R. Cohen (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report
by: Aya Tanaka, et al.
Published: (2019) -
Effects of psoralen on the pharmacokinetics of anastrozole in rats
by: Yuzhu Zhang, et al.
Published: (2018) -
Hormonal based treatment of ovarian anaplastic ependymoma with anastrozole
by: Justin Wayne Gorski, et al.
Published: (2017) -
Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation
by: Regenthal R, et al.
Published: (2018) -
Anastrozole Loaded Nanostructured Lipid Carriers : Preparation and Evaluation
by: Alaa Abdul-Jabbar Hashim, et al.
Published: (2021)